OpenLegislation

Division Aim of the testF1

United Kingdom

Original text. Later amendments are not shown.

The long-term studies conducted and reported, taken together with other relevant data and information on the active substance, must be sufficient to permit the identification of effects, following repeated exposure to the active substance, and in particular must be sufficient to:

  • identify adverse effects resulting from exposure to the active substance,

  • identify target organs, where relevant,

  • establish the dose-response relationship,

  • identify changes in toxic signs and manifestations observed, and

  • establish the Noael.

Similarly, the carcinogenicity studies taken together with other relevant data and information on the active substance, must be sufficient to permit the hazards for humans, following repeated exposure to the active substance, to be assessed, and in particular must be sufficient:

  • to identify carcinogenic effects resulting from exposure to the active substance,

  • to establish the species and organ specificity of tumours induced,

  • to establish the dose-response relationship, and

  • for non-genotoxic carcinogens, to identify the maximum dose eliciting no adverse effect (threshold dose).

Annotations

Textual amendments

F1

Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.